AGAE vs IQST

AGAE exhibits severe financial distress, as evidenced by a Piotroski F-Score of 1/9, indicating extreme operational weakness and deteriorating fundamentals. The company reports negative profitability across all key margins and returns, with a -280% profit margin and -39.54% ROE, signaling deep operational inefficiencies. Despite a low Price/Book of 0.21, the absence of a Graham Number and intrinsic value estimate, combined with negative earnings and declining revenue, undermines any potential value proposition. The stock's 5-year decline of 89.5% and lack of analyst coverage further reflect market skepticism. With no dividend and weak insider sentiment, the overall outlook remains highly unfavorable.

The company exhibits severe financial distress, highlighted by a critical Piotroski F-Score of 1/9, indicating fundamental weakness across almost all health metrics. Despite a low Price-to-Book ratio of 0.54, the business is destroying shareholder value with an ROE of -60.40% and declining quarterly revenue (-14.83%). The stock is in a precipitous long-term decline, losing 97% of its value over five years, and the single analyst target of $18.00 appears completely decoupled from current market reality and financial performance.